Villaplana, Analyn D.

HRN: 24-97-89  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2024
CEFUROXIME 1.5GM (VIAL)
05/08/2024
05/09/2024
IVT
1.5gms
Q8 Hrs
LTCS
Waiting Final Action 
05/08/2024
CEFUROXIME 500MG (TAB)
05/10/2024
05/17/2024
PO
500
BID
LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: